Daniel R. Knight PhD
Daniel R. Knight PhD
Murdoch University (Medical, Molecular and Forensic Sciences)
Verified email at murdoch.edu.au - Homepage
Cited by
Cited by
Diversity and evolution in the genome of Clostridium difficile
DR Knight, B Elliott, BJ Chang, TT Perkins, TV Riley
Clinical microbiology reviews 28 (3), 721-741, 2015
Evaluation of epidemiological cut-off values indicates that biocide resistant subpopulations are uncommon in natural isolates of clinically-relevant microorganisms
I Morrissey, MR Oggioni, D Knight, T Curiao, T Coque, A Kalkanci, ...
PloS one 9 (1), e86669, 2014
Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants of Staphylococcus aureus
L Furi, ML Ciusa, D Knight, V Di Lorenzo, N Tocci, D Cirasola, L Aragones, ...
Antimicrobial agents and chemotherapy 57 (8), 3488-3497, 2013
A novel resistance mechanism to triclosan that suggests horizontal gene transfer and demonstrates a potential selective pressure for reduced biocide susceptibility in clinical …
ML Ciusa, L Furi, D Knight, F Decorosi, M Fondi, C Raggi, JR Coelho, ...
International journal of antimicrobial agents 40 (3), 210-220, 2012
Genome Analysis of Clostridium difficile PCR Ribotype 014 Lineage in Australian Pigs and Humans Reveals a Diverse Genetic Repertoire and Signatures of Long-Range Interspecies …
DR Knight, MM Squire, DA Collins, TV Riley
Frontiers in Microbiology 7, 2138, 2017
Cross-sectional study reveals high prevalence of Clostridium difficile non-PCR ribotype 078 strains in Australian veal calves at slaughter
DR Knight, S Thean, P Putsathit, S Fenwick, TV Riley
Applied and environmental microbiology 79 (8), 2630-2635, 2013
Nationwide surveillance study of Clostridium difficile in Australian neonatal pigs shows high prevalence and heterogeneity of PCR ribotypes
DR Knight, MM Squire, TV Riley
Applied and environmental microbiology 81 (1), 119-123, 2015
Clostridium difficile infection: Evolution, phylogeny and molecular epidemiology
B Elliott, GO Androga, DR Knight, TV Riley
Infection, Genetics and Evolution, 2016
Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013–14
DR Knight, S Giglio, PG Huntington, TM Korman, D Kotsanas, CV Moore, ...
Journal of Antimicrobial Chemotherapy 70, 2992-9, 2015
Prevalence of Clostridium difficile colonization among healthcare workers
ND Friedman, J Pollard, D Stupart, DR Knight, M Khajehnoori, EK Davey, ...
BMC infectious diseases 13 (1), 1-5, 2013
Clostridium difficile Infection in Production Animals and Avian Species: A Review
RTV Moono P, Foster NF, Hampson DJ, Knight DR, Bloomfield LE
Foodborne Pathog. Dis. 13, 647-655., 2016
Peroxisomal import of human alanine: glyoxylate aminotransferase requires ancillary targeting information remote from its C terminus
PAJ Huber, GM Birdsey, MJ Lumb, DTR Prowse, TJ Perkins, DR Knight, ...
Journal of Biological Chemistry 280 (29), 27111-27120, 2005
Prevalence of gastrointestinal Clostridium difficile carriage in Australian sheep and lambs
DR Knight, TV Riley
Applied and environmental microbiology 79 (18), 5689-5692, 2013
Evolutionary and genomic insights into Clostridioides difficile sequence type 11: a diverse zoonotic and antimicrobial-resistant lineage of global one health importance
DR Knight, B Kullin, GO Androga, F Barbut, C Eckert, S Johnson, ...
MBio 10 (2), 2019
Contamination of Australian newborn calf carcasses at slaughter with Clostridium difficile
DR Knight, P Putsathit, B Elliott, TV Riley
Clinical Microbiology and Infection 22 (3), 266. e1-266. e7, 2016
Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in …
I Morrissey, H Seifert, R Canton, P Nordmann, S Stefani, A MacGowan, ...
Journal of Antimicrobial Chemotherapy 68 (1), 164-167, 2013
Significant differences characterise the correlation coefficients between biocide and antibiotic susceptibility profiles in Staphylococcus aureus
MR Oggioni, JR Coelho, L Furi, DR Knight, C Viti, G Orefici, JL Martinez, ...
Current pharmaceutical design 21 (16), 2054, 2015
The use of machine learning methodologies to analyse antibiotic and biocide susceptibility in Staphylococcus aureus
JR Coelho, JA Carriço, D Knight, JL Martínez, I Morrissey, MR Oggioni, ...
PLoS One 8 (2), e55582, 2013
Genomic delineation of zoonotic origins of Clostridium difficile
DR Knight, TV Riley
Frontiers in public health 7, 164, 2019
Clostridium difficile ribotype 017 – characterization, evolution and epidemiology of the dominant strain in Asia
K Imwattana, DR Knight, B Kullin, DA Collins, P Putsathit, P Kiratisin, ...
Emerging microbes & infections 8 (1), 796-807, 2019
The system can't perform the operation now. Try again later.
Articles 1–20